£48.00

It has never been this cheap. We have no record of a lower price.

£48 today · cheaper than every other day in the last 3 months

LAP Lambert Academic Publishing High-Risk Human Papillomavirus and Cervical Carcinoma: A Study on Human Papillomavirus: High-Risk E6, p53 and p16 Proteins Expression and Their Role in Cervical Carcinogenesis

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 64 days · 64 data points (no recent data)

Historical
Generating forecast…
£48.00 £45.60 £46.56 £47.52 £48.48 £49.44 £50.40 26 July 2026 10 August 2026 26 August 2026 11 September 2026 27 September 2026
View at Amazon ↗

Price data last checked 27 day(s) ago - will refresh soon

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 64 days • 1 price levels

Days at Price
64 days 0 16 32 48 64 £48 Days at Price

Price Analysis

Most common price: £48 (64 days, 100.0%)

Price range: £48 - £48

Price levels: 1 different prices over 64 days

Description

Cervical cancer is one of the most frequent diseases in women,it is comprises approximately 12% of all cancer in women worldwide and the second most common type, after breast cancer, with about 200,000 deaths annually and 500,000 new cases per annum. Persistent infection with one or more carcinogenic types of human papillomavirus (HPV) is an important etiologic factor in the development of cervical intraepithelial neoplasia and the progression to cervical cancer. HPV DNA has been detected in up to 99.7% of invasive cervical cancers worldwide.The carcinogenic effect of the "high-risk" HPVs, as defined by their documented association with invasive carcinomas, is thought to be mediated by two viral oncoprotein, E6 and E7, through their action of inactivating the function of two important cellular tumor suppressor, p53 and pRb. It has been demonstrated that the E6 oncoprotein interacts with p53 to promote its degradation, whereas the E7 oncoprotein form complex with Rb, leading to its functional inactivation as well as accelerated degradation. These synergistic effects result in a deregulated cell cycle control and are thus believed to be critically important in HPV-induced carcinogene

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
22 March 2013
Listed Since
26 March 2013

Barcode

No barcode data available

Similar Products You Might Like

Cancer Du Col De L’utérus Et L’infection Par Papillomavirus Humain
97% match

Cancer Du Col De L’utérus Et L’infection Par Papillomavirus Humain

ÉDITIONS UNIVERSITAIRES EUROPÉENNES

£49.00 26 Sep 2026
Topics on Cervical Cancer With an Advocacy for Prevention
97% match

Topics on Cervical Cancer With an Advocacy for Prevention

IntechOpen

£119.00 01 Oct 2026
Prévention du cancer du col de l’utérus: Intérêts des analyses morphologiques, immunohistochimiques et moléculaires (Omn.Univ.Europ.)
97% match

Prévention du cancer du col de l’utérus: Intérêts des analyses morphologiques, immunohistochimiques et moléculaires (Omn.Univ.Europ.)

ÉDITIONS UNIVERSITAIRES EUROPÉENNES

£50.00 18 Sep 2026
The 2023-2028 Outlook for Cervical Cancer Treatments in the United States
97% match

The 2023-2028 Outlook for Cervical Cancer Treatments in the United States

£520.00 25 Aug 2026
Strategies for Overcoming Chemotherapy Resistance in Cervical Cancer: From Molecular Insights to Precision Solutions (Volume 21) (Cancer Sensitizing Agents for Chemotherapy, Volume 21)
96% match

Strategies for Overcoming Chemotherapy Resistance in Cervical Cancer: From Molecular Insights to Precision Solutions (Volume 21) (Cancer Sensitizing Agents for Chemotherapy, Volume 21)

Elsevier

£124.00 03 Oct 2026
Current Topics and Prevention of Cervical Cancer
96% match

Current Topics and Prevention of Cervical Cancer

Foster Academics

£62.77 17 Sep 2026
The 2023-2028 Outlook for Cervical Cancer Diagnostic Testing in the United States
96% match

The 2023-2028 Outlook for Cervical Cancer Diagnostic Testing in the United States

£520.00 02 Oct 2026
The 2023-2028 Outlook for Cervical Cancer Treatments in India
96% match

The 2023-2028 Outlook for Cervical Cancer Treatments in India

£515.00 23 Aug 2026
Detection of human papilloma virus genome in laryngeal carcinomas: By means of in situ DNA hybridization
96% match

Detection of human papilloma virus genome in laryngeal carcinomas: By means of in situ DNA hybridization

LAP Lambert Academic Publishing

£53.87 19 Sep 2026
The 2023-2028 Outlook for Cervical Cancer Diagnostic Testing in India
96% match

The 2023-2028 Outlook for Cervical Cancer Diagnostic Testing in India

£515.00 03 Oct 2026
The 2023-2028 Outlook for Cervical Cancer Treatments in China
96% match

The 2023-2028 Outlook for Cervical Cancer Treatments in China

£495.00 23 Aug 2026
Cervical Cancer: A Guide for Nurses
96% match

Cervical Cancer: A Guide for Nurses

Wiley

£43.95 18 Sep 2026
Recent Topics on Prevention, Diagnosis, and Clinical Management of Cervical Cancer (Comprehensive Gynecology and Obstetrics)
96% match

Recent Topics on Prevention, Diagnosis, and Clinical Management of Cervical Cancer (Comprehensive Gynecology and Obstetrics)

Springer

£94.68 24 Sep 2026
The 2023-2028 World Outlook for Cervical Cancer Treatments
96% match

The 2023-2028 World Outlook for Cervical Cancer Treatments

£795.00 27 Aug 2026
The Resistance of Cervical Cancer to Chemotherapy and its Reversal (Volume 9) (Breaking Tolerance to Anti-Cancer Cell-Mediated Immunotherapy, Volume 9)
96% match

The Resistance of Cervical Cancer to Chemotherapy and its Reversal (Volume 9) (Breaking Tolerance to Anti-Cancer Cell-Mediated Immunotherapy, Volume 9)

Elsevier

£125.15 19 Sep 2026
Invasive Carcinoma of the Cervix: European Practice in Gynaecology and Obstetrics Series: 1
96% match

Invasive Carcinoma of the Cervix: European Practice in Gynaecology and Obstetrics Series: 1

Elsevier

£42.73 23 Sep 2026
Cervical Cancer: Recent Advances and New Perspectives
96% match

Cervical Cancer: Recent Advances and New Perspectives

IntechOpen

£95.00 22 Sep 2026
What Every Woman Should Know about Cervical Cancer: Revised and Updated
96% match

What Every Woman Should Know about Cervical Cancer: Revised and Updated

Springer

£107.47 18 Sep 2026
Open, Laparoscopic, and Robotic Surgery for Cervical Cancer
96% match

Open, Laparoscopic, and Robotic Surgery for Cervical Cancer

Springer

£80.67 18 Sep 2026
Cervical Cancer: A Global Public Health Treatise
96% match

Cervical Cancer: A Global Public Health Treatise

IntechOpen

£119.00 25 Sep 2026
Cervical Cancer
96% match

Cervical Cancer

Springer

£117.61 01 Oct 2026
The 2023-2028 Outlook for Pap Smear Tests for Cervical Cancer Diagnostic Testing for US Zip Codes
96% match

The 2023-2028 Outlook for Pap Smear Tests for Cervical Cancer Diagnostic Testing for US Zip Codes

£490.00 05 Sep 2026
The 2023-2028 Outlook for Cervical Cancer Treatments for US Zip Codes
96% match

The 2023-2028 Outlook for Cervical Cancer Treatments for US Zip Codes

£490.00 26 Aug 2026
Burghardt's Colposcopy and Cervical Pathology: Textbook and Atlas
96% match

Burghardt's Colposcopy and Cervical Pathology: Textbook and Atlas

Thieme

£126.64 24 Sep 2026